(Press-News.org) Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in its collaboration with Fosun Pharma in June 2024, a potential innovative therapeutic using synthetic lethal strategy for the treatment of solid tumors. Insilico expects to submit the pre-IND application for this candidate with the CDE in 2024 Q4.
When initiating the collaboration, Fosun Pharma proposed four targets of interest, and the target of the PCC nominated in this program is one of them and plays a critical role in DNA damage repair mechanisms. Insilico’s R&D team fully analyzed and validated the target through PandaOmics, an AI target identification engine, in combination with Life Star 1, an AI-driven robotics lab. Then, scientists utilized Chemistry42, a generative chemistry engine, to generate and design compounds from scratch for the specified target.
In preclinical studies, the candidate demonstrated good selectivity, robust anti-tumor efficacy as well as promising ADMET properties. The preclinical data of this program has been recognized by Fosun Pharma and meets both parties’ criteria for PCC nomination. Insilico will advance the candidate to the IND-enabling stage and then Fosun Pharma will take over for further research and exploration.
“We are delighted to deliver the PCC milestone of this program to Fosun Pharma with the support of Insilico’s proprietary AI platform,” said Feng Ren, PhD, co-CEO, and Chief Scientific Officer of Insilico Medicine, “Candidates targeting DNA repair mechanisms play an increasingly important role in tumor therapy. I am impressed by our partner’s vision and positive endorsement of AI-driven drug discovery. In partnering with Fosun Pharma, Insilico aims to take AI-driven drug discovery to the next level for the benefit of patients worldwide.”
“AI, as a revolutionary tool for discovering innovative drugs, is continuously deepening and expanding its innovation empowerment in the medical field. We are excited to mark the significant milestone of PCC nomination, it’s an innovative therapy potentially treating solid tumors through synthetic lethal strategy. We look forward to achieving more inspiring outcomes in the collaboration with Insilico Medicine,” says Xingli Wang, MD, PhD, CEO of Global R&D Center, and Executive President of Fosun Pharma. “As an innovation-driven pharmaceutical company, Fosun Pharma strives to address unmet medical needs and enhance patient accessibility to safe and effective drugs through continuous innovation and joint efforts with our partners.”
In January 2022, Insilico Medicine announced a strategic collaboration with Fosun Pharma to proceed generative AI-driven drug discovery programs globally. Just one month after the collaboration, Insilico delivered the first PCC for QPCTL program, which is conducting a Phase I clinical trial in China and recently completed the first-in-patient dose for the treatment of advanced malignant tumors.
Founded in 2014, Insilico Medicine is a pioneer in using generative AI for drug discovery and development. Insilico first described the concept of using generative AI for the design of novel molecules in a peer-reviewed journal in 2016, which laid the foundation for the commercially available Pharma.AI platform spanning across biology, chemistry and clinical development. Powered by Pharma.AI, Insilico has nominated 18 preclinical candidates in its comprehensive portfolio of over 30 assets since 2021, and has received IND approval for 7 molecules. Recently, the company published a paper in Nature Biotechnology presenting the entire R&D journey of its lead drug pipeline, INS018_055, from AI algorithms to Phase II clinical trials.
About Insilico Medicine
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.com
About Fosun Pharma
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products. Fosun Pharma’s innovative products mainly covered core therapeutic areas such as tumors (solid tumors and hematologic tumors), immunology, central nervous system, and chronic diseases (liver disease/metabolism/kidney disease).
Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma will uphold the development model of “Innovation Transformation, Integrated Operation and Steady Growth", with the mission of creating shareholder values through strengthening its independent R&D and external cooperation and enriching its product pipelines, as well as promoting the global networks and enhancing operational efficiency. Fosun Pharma will actively promote key business and rapidly enhance operational and asset efficiency, and is committed to becoming a first-class enterprise in the global major pharmaceutical and healthcare market.
For more information, please visit our official website: www.fosunpharma.com
END
Insilico delivers second preclinical candidate compound (PCC) to Fosun Pharma
2024-07-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Gondwana’s ultimate hunter – New giant fossil tetrapod found in Namibia
2024-07-05
After three years of meticulous study, an international team of researchers has announced the discovery of a fossilised giant basal tetrapod in Namibia's arid heartland in Nature. A basal tetrapod is an early four-legged vertebrate with fingers and toes, which lived during the transition from water to land. These ancient carnivores are among the earliest ancestors of all modern animals. This nearly complete 3-meter-long skeleton of an adult, unearthed in the Ugab River valley in Damaraland, is the largest ever discovered. This discovery is significant because it challenges previous assumptions that these early four-legged vertebrates, which lived during ...
Offshore windfarms – A threat for electro-sensitive sharks?
2024-07-05
An ongoing research project into the impact of offshore windfarm electromagnetic fields on shark development reveals that the alternating electric currents produced by underwater windfarm cables seems not to disrupt the growth or survival of sharks.
Offshore windfarms are one of the most common marine renewable energy (MRE) producers, and are seen as a pivotal technology in the global transition towards renewable energy and away from fossil fuels that contribute to climate change.
However, their proliferation in marine environments raises new questions about their impacts on wildlife. Energy operators and ...
A 2D device for quantum cooling
2024-07-05
To perform quantum computations, quantum bits (qubits) must be cooled down to temperatures in the millikelvin range (close to -273 Celsius), to slow down atomic motion and minimize noise. However, the electronics used to manage these quantum circuits generate heat, which is difficult to remove at such low temperatures. Most current technologies must therefore separate quantum circuits from their electronic components, causing noise and inefficiencies that hinder the realization of larger quantum systems beyond the lab.
Researchers in EPFL’s Laboratory of ...
MIT engineers find a way to protect microbes from extreme conditions
2024-07-05
Microbes that are used for health, agricultural, or other applications need to be able to withstand extreme conditions, and ideally the manufacturing processes used to make tablets for long-term storage. MIT researchers have now developed a new way to make microbes hardy enough to withstand these extreme conditions.
Their method involves mixing bacteria with food and drug additives from a list of compounds that the FDA classifies as “generally regarded as safe.” The researchers identified formulations that help to stabilize several different types ...
Why the U.S. food system needs agroecology
2024-07-05
Agroecology—a science, practice, and movement which seeks social, political, economic, and environmental sustainability in the global food system—is gaining momentum in the U.S., according to a new Dartmouth-led commentary in Nature Food. As the co-authors report, the approach requires coordination between scientists, farmers, and activists.
"When it comes to sustainable food and agriculture, people in the U.S. tend to be more familiar with organic farming, the production of food without synthetic inputs, and regenerative agriculture, which primarily strives to restore soil health," says lead author Theresa Ong, an assistant professor of environmental studies ...
Fresh wind blows from historical supernova
2024-07-05
A mysterious remnant from a rare type of supernova recorded in 1181 has been explained for the first time. Two white dwarf stars collided, creating a temporary “guest star,” now labeled supernova (SN) 1181, which was recorded in historical documents in Japan and elsewhere in Asia. However, after the star dimmed, its location and structure remained a mystery until a team pinpointed its location in 2021. Now, through computer modeling and observational analysis, researchers have recreated the structure of the remnant white dwarf, a rare occurrence, explaining its ...
Desert-loving fungi and lichens pose deadly threat to 5,000-year-old rock art
2024-07-05
The Negev desert of southern Israel is renowned for its unique rock art. Since at least the third millennium BCE, the hunters, shepherds, and merchants who roamed the Negev have left thousands of carvings (‘petroglyphs’) on the rocks. These figures are mostly cut into ‘desert varnish’: a thin black coating on limestone rock, which forms naturally. Many represent animals such as ibexes, goats, horses, donkeys, and domestic camels, but abstract forms also occur.
Now, a study published in Frontiers in Fungal ...
Scientists map how deadly bacteria evolved to become epidemic
2024-07-04
Pseudomonas aeruginosa – an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions – evolved rapidly and then spread globally over the last 200 years, probably driven by changes in human behaviour, a new study has found.
P. aeruginosa is responsible for over 500,000 deaths per year around the world, of which over 300,000 are associated with antimicrobial resistance (AMR). People with conditions such as COPD (smoking-related lung damage), cystic fibrosis (CF), and non-CF bronchiectasis, are particularly susceptible.
How P. aeruginosa evolved from an environmental organism into a ...
Biodegradable biomass-based aerogel for sustainable radiative cooling
2024-07-04
An aerogel made from gelatin and DNA surpasses 100% solar reflectance, yielding exceptional radiative cooling, a new study reports. It is also biodegradable. The novel approach paves the way for high-performance next-generation radiative cooling materials, promoting environmentally friendly advancements in the field. Sustainable, energy-efficient, and environmentally conscious cooling technologies are crucial for adapting to our rapidly warming world. Compared to traditional refrigeration systems, passive radiative cooling technologies consume less energy and emit fewer greenhouse gasses, making them ...
New brain-to-nerve signaling mechanism reveals potential path to migraine pain
2024-07-04
The rapid influx of cerebral spinal fluid (CSF) and protein solutes released during cortical spreading depression (CSD) in the brain activates neurons to trigger aural migraine headaches, according to a new mouse study. The findings identify a novel non-synaptic signaling mechanism between the brain and peripheral sensory system important for migraine. They also suggest potential pharmacological targets for treating the painful disorder. Migraine with aura, or an aural migraine, is a distinct headache disorder that can include sensory disturbances, such as hearing- or vision-related symptoms that precede onset of ...